DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Brooks Laboratories Limited (BROOKS) share price today?

Brooks Laboratories Limited (BROOKS) is trading at ₹67 on the NSE, down 4.86% on the day. Source: DocStoX.

What is the PE ratio of Brooks Laboratories Limited?

Brooks Laboratories Limited has a price-to-earnings (PE) ratio of 8.0 in the Healthcare sector.

What is the market capitalisation of Brooks Laboratories Limited?

Brooks Laboratories Limited has a market capitalisation of approximately ₹200 crore.

Is Brooks Laboratories Limited a profitable company?

Brooks Laboratories Limited generates a return on equity of 20.0% with a net profit margin of 28.7%. That is a strong return on shareholder capital.

What is the 52-week high and low of BROOKS?

Brooks Laboratories Limited (BROOKS) has traded between ₹36.3 and ₹126.43 over the past 52 weeks, against a current price of ₹67.

Brooks Laboratories Limited

₹67.00▼ -3.42 (-4.86%)

BROOKS·NSE·Healthcare

Market Cap

199.84 Cr

PE Ratio

8.02

Volume

1,22,150

Day High - Low

72.50 - 66.55

52W High-Low

126.43 - 36.30

₹67.00▼ -3.42 (-4.86%)

Market Cap199.84 Cr

PE Ratio8.02

Volume1,22,150

Day High - Low72.50 - 66.55

52W High-Low126.43 - 36.30

Brooks Laboratories Limited (BROOKS): company summary

The company's annual revenue rose 3.3% to ₹86 crore, but the latest quarter's revenue fell 10.0% to ₹23 crore compared to the same quarter a year earlier.

Brooks Laboratories Limited (BROOKS) is a micro-cap Healthcare company valued at ₹200 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move: Brooks Laboratories Limited last traded at ₹67, down 4.86% on the day.
Recent developments: On 2026-06-30, the company reported a net profit loss of ₹2 crore for the latest quarter, reversing a profit of ₹10 crore in the same quarter a year earlier. Promoter holding remained at 52.62% as of 2026-06-30, while foreign institutional holding dropped to 0.00%.
Financial performance: The company's annual revenue rose 3.3% to ₹86 crore, but the latest quarter's revenue fell 10.0% to ₹23 crore compared to the same quarter a year earlier. Net profit margin improved 40.7 percentage points to 28.7%, but the latest quarter's net profit swung from a profit of ₹10 crore to a loss of ₹2 crore.
Valuation multiples: The stock trades at 8.0 times earnings, a discount to the Healthcare median of 32.0, 1.53 times book value.
Things to watch: The latest quarter's net profit swung to a loss of ₹2 crore, falling from a profit of ₹10 crore a year earlier. The stock is 60.4% below its 52-week high, and the latest quarter's revenue fell 10.0% to ₹23 crore.
Where it stands: The company's annual net profit swung from a loss of ₹10 crore to a profit of ₹25 crore, while the latest quarter's net profit turned to a loss of ₹2 crore. The stock is 60.4% below its 52-week high.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

5.2/10

Weak

Fair Value

ROE

20.02%

Strong

P/E

8.02x

Cheap

Debt / Equity

0.07

Low

Industry

Healthcare

Pharmaceuticals

Overall View

Mixed

Price performance

Day₹66.55

₹72.50

52W₹36.30

₹126.43

DocStoX take

Supported by valuation (9.0), but held back by momentum (2.7). Valuation looks strong at 9.0, but that is offset by momentum at 2.7. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence

5.2

/10

Weak

Quality

Modest

ROE 20.0%

Valuation

Cheap

P/E 8.0×

Growth

Slow

Revenue +2.2% 5Y CAGR

Risk

Moderate

D/E 0.07

Momentum

Weak

34% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹67

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹200 Cr

52W High / Low

₹126 / ₹36

Dividend Yield

0.00%

Promoter Holding

52.62%

EPS (TTM)

₹8.35

Book Value

₹41.64

Key highlights

Low leverage — D/E 0.07
Healthy net margin (29%)
Undemanding at 8× earnings
Loss-making in some of the last 5 years
Revenue barely growing (2% a year)

4 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Brooks Laboratories Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Brooks Laboratories Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Brooks Laboratories Limited with peers

Brooks Laboratories Limited vs Sun Pharmaceutical Industries Limited Brooks Laboratories Limited vs Divi's Laboratories Limited Brooks Laboratories Limited vs Torrent Pharmaceuticals Limited Brooks Laboratories Limited vs Apollo Hospitals Enterprise Limited Brooks Laboratories Limited vs Zydus Lifesciences Limited Brooks Laboratories Limited vs Laurus Labs Limited

Related tools & concepts

Value Brooks Laboratories Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

BROOKS newsLatest coverage & filings Open screenerFilter the whole market